MACROGENICS INC — Director's Dealing 2022

Jun 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2022-06-15

Reporting Person: Karrels James (SVP, CFO and Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-15	Common Stock	P	40000	$2.47	Acquired	191776	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $2.435 to $2.50. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

F2: Owned jointly with reporting person's wife.